Dow Down0.32% Nasdaq Down0.62%

More On RANBAXY.NS

Quotes

Charts

News & Info

Company

  • Profile
  • Key Statistics
  • SEC Filings
  • Competitors
  • Industry
  • Components

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Ranbaxy Laboratories Ltd. (RANBAXY.NS)

-NSI
859.80 0.00(0.00%) N/A
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Dec 31, 2012Dec 31, 2011
Net Income (12,110,000) (10,116,000) 9,228,000   (28,997,000)
Operating Activities, Cash Flows Provided By or Used In
Depreciation3,198,000   -  3,000,000  2,903,000  
Adjustments To Net Income -   -   -   -  
Changes In Accounts Receivables646,000   -  10,857,000  (11,707,000)
Changes In Liabilities -   -   -   -  
Changes In Inventories148,000   -  (882,000)(3,097,000)
Changes In Other Operating Activities(440,000) -  1,082,000  (1,087,000)
Total Cash Flow From Operating Activities (28,499,000) -   15,821,000   6,388,000  
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(6,247,000) -  (4,767,000)(4,773,000)
Investments -   -   -   -  
Other Cash flows from Investing Activities -   -   -   -  
Total Cash Flows From Investing Activities 14,656,000   -   (18,203,000) 16,687,000  
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -   -  
Sale Purchase of Stock -   -   -   -  
Net Borrowings -   -   -   -  
Other Cash Flows from Financing Activities20,843,000   -  (13,533,000)20,951,000  
Total Cash Flows From Financing Activities 8,129,000   -   2,369,000   (12,177,000)
Effect Of Exchange Rate Changes1,009,000   -  (510,000)1,119,000  
Change In Cash and Cash Equivalents (4,705,000) -   (523,000) 12,017,000  

Currency in INR.